{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T21:33:16Z","timestamp":1770240796090,"version":"3.49.0"},"reference-count":64,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"ESF Baden W\u00fcrttemberg (www.esf-bw.de) and the Ministerium f\u00fcr Wissenschaft, Forschung und Kunst, Baden W\u00fcrttemberg","award":["Margarete von Wrangell Stipend"],"award-info":[{"award-number":["Margarete von Wrangell Stipend"]}]},{"name":"EU","award":["IT-Liver consortium"],"award-info":[{"award-number":["IT-Liver consortium"]}]},{"DOI":"10.13039\/501100001646","name":"Robert Bosch Stiftung","doi-asserted-by":"publisher","award":["non"],"award-info":[{"award-number":["non"]}],"id":[{"id":"10.13039\/501100001646","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Isarna Therapeutics GmbH","award":["non"],"award-info":[{"award-number":["non"]}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["PTJ-031L0043"],"award-info":[{"award-number":["PTJ-031L0043"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SPP 1937","award":["CE140\/2-1"],"award-info":[{"award-number":["CE140\/2-1"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1366"],"award-info":[{"award-number":["SFB1366"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2019,12,17]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>TGF-\u03b22 (TGF-\u03b2, transforming growth factor beta), the less-investigated sibling of TGF-\u03b21, is deregulated in rodent and human liver diseases. Former data from bile duct ligated and MDR2 knockout (KO) mouse models for human cholestatic liver disease suggested an involvement of TGF-\u03b22 in biliary-derived liver diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>As we also found upregulated <jats:italic>TGFB2<\/jats:italic> in liver tissue of patients with primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), we now fathomed the positive prospects of targeting TGF-\u03b22 in early stage biliary liver disease using the MDR2-KO mice. Specifically, the influence of <jats:italic>TgfB2<\/jats:italic> silencing on the fibrotic and inflammatory niche was analysed on molecular, cellular and tissue levels.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                     <jats:italic>TgfB2<\/jats:italic>-induced expression of fibrotic genes in cholangiocytes and hepatic stellate cellswas detected. <jats:italic>TgfB2<\/jats:italic> expression in MDR2-KO mice was blunted using <jats:italic>TgfB2<\/jats:italic>-directed antisense oligonucleotides (AON). Upon AON treatment, reduced collagen deposition, hydroxyproline content and \u03b1SMA expression as well as induced <jats:italic>PparG<\/jats:italic> expression reflected a significant reduction of fibrogenesis without adverse effects on healthy livers. Expression analyses of fibrotic and inflammatory genes revealed AON-specific regulatory effects on <jats:italic>Ccl3<\/jats:italic>, <jats:italic>Ccl4<\/jats:italic>, <jats:italic>Ccl5<\/jats:italic>, <jats:italic>Mki67<\/jats:italic> and <jats:italic>Notch3<\/jats:italic> expression. Further, AON treatment of MDR2-KO mice increased tissue infiltration by F4\/80-positive cells including eosinophils, whereas the number of CD45-positive inflammatory cells decreased. In line, <jats:italic>TGFB2<\/jats:italic> and CD45 expression correlated positively in PSC\/PBC patients and localised in similar areas of the diseased liver tissue.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Taken together, our data suggest a new mechanistic explanation for amelioration of fibrogenesis by TGF-\u03b22 silencing and provide a direct rationale for TGF-\u03b22-directed drug development.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/gutjnl-2019-319091","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T16:17:00Z","timestamp":1580228220000},"page":"1677-1690","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":40,"title":["TGF-\u03b22 silencing to target biliary-derived liver diseases"],"prefix":"10.1136","volume":"69","author":[{"given":"Anne","family":"Dropmann","sequence":"first","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-6240","authenticated-orcid":false,"given":"Steven","family":"Dooley","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedair","family":"Dewidar","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"},{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seddik","family":"Hammad","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"},{"name":"Department of Forensic Medicine and Toxicology, Faculty of Veterinary Medicine, South Valley University, Qena, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Dediulia","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Werle","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Hartwig","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrouz","family":"Ghafoory","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Woelfl","sequence":"additional","affiliation":[{"name":"Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Korhonen","sequence":"additional","affiliation":[{"name":"Isarna Therapeutics GmbH, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Janicot","sequence":"additional","affiliation":[{"name":"Isarna Therapeutics GmbH, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Wosikowski","sequence":"additional","affiliation":[{"name":"Isarna Therapeutics GmbH, Munchen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Itzel","sequence":"additional","affiliation":[{"name":"Hepatology and Clinical Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7953-8927","authenticated-orcid":false,"given":"Andreas","family":"Teufel","sequence":"additional","affiliation":[{"name":"Hepatology and Clinical Bioinformatics, Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3135-1359","authenticated-orcid":false,"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[{"name":"Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany"},{"name":"Institute of Translational Immunology, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany"},{"name":"Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Department of Immunobiochemistry, Centre for Biomedicine and Medical Technology (CBTM) and European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelheid","family":"Cerwenka","sequence":"additional","affiliation":[{"name":"Department of Immunobiochemistry, Centre for Biomedicine and Medical Technology (CBTM) and European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Nittka","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry, Medical Faculty Mannheim of the University of Heidelberg, University Hospital Mannheim, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albrecht","family":"Piiper","sequence":"additional","affiliation":[{"name":"Medizinische Klinik 1, Klinikum der Goethe-Universit\u00e4t, Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6022-073X","authenticated-orcid":false,"given":"Timo","family":"Gaiser","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiara","family":"Beraza","sequence":"additional","affiliation":[{"name":"Gut Microbes and Health Institute Strategic Programme, Quadram Institute, Norwich, UK"},{"name":"CIC bioGUNE, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Derio, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Milkiewicz","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Pomeranian Medical University, Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Milkiewicz","sequence":"additional","affiliation":[{"name":"Liver and Internal Medicine Unit, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G","family":"Brain","sequence":"additional","affiliation":[{"name":"NIHR Applied Immunobiology and Transplant Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E J","family":"Jones","sequence":"additional","affiliation":[{"name":"NIHR Applied Immunobiology and Transplant Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0336-0581","authenticated-orcid":false,"given":"Thomas S","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Juvenile Medicine, Center for Liver Cell Research, University of Regensburg Hospital, Regensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich M","family":"Zanger","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cell Biology, Dr Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany"},{"name":"Eberhard-Karls-University T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Ebert","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0211-352X","authenticated-orcid":false,"given":"Nadja M","family":"Meindl-Beinker","sequence":"additional","affiliation":[{"name":"Molecular Hepatology-Alcohol Associated Diseases, Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"2025090723364260000_69.9.1677.1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000440705","article-title":"Worldwide incidence of autoimmune liver disease","volume":"33 Suppl 2","author":"Jepsen","year":"2015","journal-title":"Dig Dis"},{"key":"2025090723364260000_69.9.1677.2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v8.i28.1157","article-title":"Cirrhosis and autoimmune liver disease: current understanding","volume":"8","author":"Liberal","year":"2016","journal-title":"World J Hepatol"},{"key":"2025090723364260000_69.9.1677.3","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36027"},{"key":"2025090723364260000_69.9.1677.4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0016-5085(86)90972-8","article-title":"Azathioprine and prognosis in primary biliary cirrhosis","volume":"90","author":"Christensen","year":"1986","journal-title":"Gastroenterology"},{"key":"2025090723364260000_69.9.1677.5","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.4.610"},{"key":"2025090723364260000_69.9.1677.6","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.4.562"},{"key":"2025090723364260000_69.9.1677.7","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36088"},{"key":"2025090723364260000_69.9.1677.8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118055"},{"key":"2025090723364260000_69.9.1677.9","first-page":"4479","article-title":"Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway","volume":"9","author":"Herbertz","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"2025090723364260000_69.9.1677.10","first-page":"1221","article-title":"Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease","volume":"139","author":"Milani","year":"1991","journal-title":"Am J Pathol"},{"key":"2025090723364260000_69.9.1677.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80257-7"},{"key":"2025090723364260000_69.9.1677.12","first-page":"981","article-title":"Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis","volume":"150","author":"Coker","year":"1997","journal-title":"Am J Pathol"},{"key":"2025090723364260000_69.9.1677.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-475X.1996.40217.x"},{"key":"2025090723364260000_69.9.1677.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2004.01.003"},{"key":"2025090723364260000_69.9.1677.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(99)00012-4"},{"key":"2025090723364260000_69.9.1677.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.003"},{"key":"2025090723364260000_69.9.1677.17","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs208"},{"key":"2025090723364260000_69.9.1677.18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26577"},{"key":"2025090723364260000_69.9.1677.19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.27277","article-title":"Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway","volume":"60","author":"Shirasaki","year":"2014","journal-title":"Hepatology"},{"key":"2025090723364260000_69.9.1677.20","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0892"},{"key":"2025090723364260000_69.9.1677.21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008411","article-title":"A Wnt-TGF\u03b22 axis induces a fibrogenic program in muscle stem cells from dystrophic mice","volume":"6","author":"Biressi","year":"2014","journal-title":"Sci Transl Med"},{"key":"2025090723364260000_69.9.1677.22","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-013-1895-0"},{"key":"2025090723364260000_69.9.1677.23","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.009"},{"key":"2025090723364260000_69.9.1677.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.07.019"},{"key":"2025090723364260000_69.9.1677.25","doi-asserted-by":"crossref","first-page":"19499","DOI":"10.18632\/oncotarget.6967","article-title":"TGF-\u03b21 and TGF-\u03b22 abundance in liver diseases of mice and men","volume":"7","author":"Dropmann","year":"2016","journal-title":"Oncotarget"},{"key":"2025090723364260000_69.9.1677.26","first-page":"1237","article-title":"Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis","volume":"145","author":"Mauad","year":"1994","journal-title":"Am J Pathol"},{"key":"2025090723364260000_69.9.1677.27","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-209379"},{"key":"2025090723364260000_69.9.1677.28","doi-asserted-by":"publisher","DOI":"10.1038\/nature02924"},{"key":"2025090723364260000_69.9.1677.29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4939-2727-2_9","article-title":"Design and selection of antisense oligonucleotides targeting transforming growth factor beta (TGF-\u03b2) isoform mRNAs for the treatment of solid tumors","volume":"1317","author":"Jaschinski","year":"2015","journal-title":"Methods Mol Biol"},{"key":"2025090723364260000_69.9.1677.30","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/annonc\/mdx314","article-title":"An antisense oligonucleotide targeting TGF-\u03b22 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophages","volume":"28","author":"Huber-Ruano","year":"2017","journal-title":"Ann Oncol"},{"key":"2025090723364260000_69.9.1677.31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.10.018"},{"key":"2025090723364260000_69.9.1677.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176518","article-title":"Ductular reaction correlates with fibrogenesis but does not contribute to liver regeneration in experimental fibrosis models","volume":"12","author":"R\u00f3kusz","year":"2017","journal-title":"PLoS One"},{"key":"2025090723364260000_69.9.1677.33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","article-title":"A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer","volume":"185","author":"Ikenaga","year":"2015","journal-title":"Am J Pathol"},{"key":"2025090723364260000_69.9.1677.34","doi-asserted-by":"publisher","DOI":"10.1038\/nature03988"},{"key":"2025090723364260000_69.9.1677.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2009.06.009"},{"key":"2025090723364260000_69.9.1677.36","doi-asserted-by":"publisher","DOI":"10.1002\/path.2993"},{"key":"2025090723364260000_69.9.1677.37","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2010.24"},{"key":"2025090723364260000_69.9.1677.38","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3810"},{"key":"2025090723364260000_69.9.1677.39","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0978"},{"key":"2025090723364260000_69.9.1677.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.03.050"},{"key":"2025090723364260000_69.9.1677.41","doi-asserted-by":"publisher","DOI":"10.1016\/0167-7799(96)10053-6"},{"key":"2025090723364260000_69.9.1677.42","doi-asserted-by":"publisher","DOI":"10.1002\/bies.950171210"},{"key":"2025090723364260000_69.9.1677.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(96)01002-4"},{"key":"2025090723364260000_69.9.1677.44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg185"},{"key":"2025090723364260000_69.9.1677.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.02.003"},{"key":"2025090723364260000_69.9.1677.46","first-page":"3200","article-title":"Antisense oligonucleotides specific for transforming growth factor beta2 inhibit the growth of malignant mesothelioma both in vitro and in vivo","volume":"57","author":"Marzo","year":"1997","journal-title":"Cancer Res"},{"key":"2025090723364260000_69.9.1677.47","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1007\/s10620-009-0858-5","article-title":"Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis","volume":"55","author":"Nie","year":"2010","journal-title":"Dig Dis Sci"},{"key":"2025090723364260000_69.9.1677.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1067-1927.2004.012112.x"},{"key":"2025090723364260000_69.9.1677.49","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.09.016"},{"key":"2025090723364260000_69.9.1677.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407250"},{"key":"2025090723364260000_69.9.1677.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2012.05.026"},{"key":"2025090723364260000_69.9.1677.52","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.043"},{"key":"2025090723364260000_69.9.1677.53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front Immunol"},{"key":"2025090723364260000_69.9.1677.54","doi-asserted-by":"publisher","DOI":"10.1038\/nature12034"},{"key":"2025090723364260000_69.9.1677.55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000371","article-title":"Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis","volume":"5","author":"Pesce","year":"2009","journal-title":"PLoS Pathog"},{"key":"2025090723364260000_69.9.1677.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.008"},{"key":"2025090723364260000_69.9.1677.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.026"},{"key":"2025090723364260000_69.9.1677.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.12.025"},{"key":"2025090723364260000_69.9.1677.59","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J Hepatol"},{"key":"2025090723364260000_69.9.1677.60","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1304046110"},{"key":"2025090723364260000_69.9.1677.61","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25880"},{"key":"2025090723364260000_69.9.1677.62","doi-asserted-by":"publisher","DOI":"10.1038\/nri3623"},{"key":"2025090723364260000_69.9.1677.63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2019.01.005","article-title":"Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: from occurrence to end stage of disease","volume":"69","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2025090723364260000_69.9.1677.64","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.12659\/MSM.899725","article-title":"Immune regulation of intrahepatic regulatory T cells in fibrotic livers of mice","volume":"23","author":"Zhang","year":"2017","journal-title":"Med Sci Monit"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2019-319091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:36:51Z","timestamp":1757313411000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2019-319091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":64,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,10]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/gutjnl-2019-319091"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2019-319091","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]}}}